EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC-ND 4.0

Determination of the clinical relevance of donor epitope‐specific HLA ‐antibodies in kidney transplantation

Tineke Kardol-Hoefnagel iD, Danial Mohammadi Senejohnny, Elena G Kamburova, Bram W Wisse, Leon Reteig, Maartje L Gruijters, Irma Joosten, Wil A Allebes, Arnold van der Meer, Luuk B Hilbrands, Marije C Baas, Eric Spierings iD und 38 weitere

HLA · 2024

DOI: 10.1111/tan.15346 ↗

Kurz gefasst

Kommentar in der Zeitschrift HLA, 2024. Verfasst von Tineke Kardol-Hoefnagel und 49 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nierstichting, Dutch Kidney Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In kidney transplantation, survival rates are still partly impaired due to the deleterious effects of donor specific HLA antibodies (DSA). However, not all luminex‐defined DSA appear to be clinically relevant. Further analysis of DSA recognizing polymorphic amino acid configurations, called eplets or functional epitopes, might improve the discrimination between clinically relevant vs. irrelevant HLA antibodies. To evaluate which donor epitope‐specific HLA antibodies (DESAs) are clinically important in kidney graft survival, relevant and irrelevant DESAs were discerned in a Dutch cohort of 4690 patients using Kaplan–Meier analysis and tested in a cox proportional hazard (CPH) model including nonimmunological variables. Pre‐transplant DESAs were detected in 439 patients (9.4%). The presence of certain clinically relevant DESAs was significantly associated with increased risk on graft loss in deceased donor transplantations ( p < 0.0001). The antibodies recognized six epitopes of HLA Class I, 3 of HLA‐DR, and 1 of HLA‐DQ, and most antibodies were directed to HLA‐B (47%). Fifty‐three patients (69.7%) had DESA against one donor epitope (range 1–5). Long‐term graft survival rate in patients with clinically relevant DESA was 32%, rendering DESA a superior parameter to classical DSA (60%). In the CPH model, the hazard ratio (95% CI) of clinically relevant DESAs was 2.45 (1.84–3.25) in deceased donation, and 2.22 (1.25–3.95) in living donation. In conclusion, the developed model shows the deleterious effect of clinically relevant DESAs on graft outcome which outperformed traditional DSA‐based risk analysis on antigen level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansEpitopesHLA AntigensClinical RelevanceIsoantibodiesAllelesTissue DonorsGraft Rejection

Stichwörter der Autor:innen

donor epitope specific antibodiesgraft survivalkidney transplantation

Substanzen

EpitopesHLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Central Diagnostic Laboratory (CDL), University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Tineke Kardol-Hoefnagel, Eric Spierings, Wendy Swelsen, Maarten Naesens, Sebastiaan Heidt

Förderung

  • Nierstichting
  • Dutch Kidney Foundation

Zitieren

APA

Kardol-Hoefnagel, T., Senejohnny, D. M., Kamburova, E. G., Wisse, B. W., Reteig, L., Gruijters, M. L., Joosten, I., Allebes, W. A., van der Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., van Reekum, F. E., van Zuilen, A. D., Verhaar, M. C., Bots, M. L., Drop, A. C. A. D., Plaisier, L., …, & Otten, H. G. (2024). Determination of the clinical relevance of donor epitope‐specific HLA ‐antibodies in kidney transplantation. HLA. https://doi.org/10.1111/tan.15346

Vancouver

Kardol-Hoefnagel T, Senejohnny DM, Kamburova EG, Wisse BW, Reteig L, Gruijters ML, et al. Determination of the clinical relevance of donor epitope‐specific HLA ‐antibodies in kidney transplantation. HLA. 2024. doi:10.1111/tan.15346

BibTeX
@article{KardolHoefnagel2024,
  author = {Kardol-Hoefnagel, Tineke and Senejohnny, Danial Mohammadi and Kamburova, Elena G and Wisse, Bram W and Reteig, Leon and Gruijters, Maartje L and Joosten, Irma and Allebes, Wil A and van der Meer, Arnold and Hilbrands, Luuk B and Baas, Marije C and Spierings, Eric and Hack, Cornelis E and van Reekum, Franka E and van Zuilen, Arjan D and Verhaar, Marianne C and Bots, Michiel L and Drop, Adriaan C A D and Plaisier, Loes and Melchers, Rowena C A and Seelen, Marc A J and Sanders, Jan Stephan and Hepkema, Bouke G and Lambeck, Annechien J A and Bungener, Laura B and Roozendaal, Caroline and Tilanus, Marcel G J and Voorter, Christina E and Wieten, Lotte and van Duijnhoven, Elly M and Gelens, Mariëlle A C J and Christiaans, Maarten H L and van Ittersum, Frans J and Nurmohamed, Shaikh A and Lardy, Neubury M and Swelsen, Wendy and van der Pant, Karlijn A M I and van der Weerd, Neelke C and Ten Berge, Ineke J M and Hoitsma, Andries and van der Boog, Paul J M and de Fijter, Johan W and Betjes, Michiel G H and Roelen, Dave L and Claas, Frans H and Bemelman, Frederike J and Senev, Aleksandar and Naesens, Maarten and Heidt, Sebastiaan and Otten, Henny G},
  title = {Determination of the clinical relevance of donor epitope‐specific HLA ‐antibodies in kidney transplantation},
  journal = {HLA},
  year = {2024},
  doi = {10.1111/tan.15346}
}
Kostenlos starten →